Showing results (561-570 of 1,408) with videos related to
Sort By:
Pageof 141
NPJ Parkinson'S Disease|February 7, 2023
Alterations in the LRRK2-Rab pathway in urinary extracellular vesicles as Parkinson's disease and pharmacodynamic biomarkersJean-Marc Taymans, Eugénie Mutez, William Sibran, et al.NPJ Parkinson'S Disease|November 15, 2022
MRI biomarkers of freezing of gait development in Parkinson's diseaseElisabetta Sarasso, Silvia Basaia, Camilla Cividini, et al.NPJ Parkinson'S Disease|February 7, 2026
LRRK2R1627P mutation amplifies environmental risk factors induced chronic inflammation and α-synuclein aggregation in the gut of ratsShimin Pang, Jing Lu, Yanyan Wang, et al.NPJ Parkinson'S Disease|December 9, 2025
Brain-derived extracellular vesicle proteomics reveals neuroprotection induced by the ARB candesartan in Parkinson's disease patientsLaura Camacho-Meño, Carmen M Labandeira, Susana B Bravo, et al.NPJ Parkinson'S Disease|December 8, 2025
Classifying the risk of cognitive impairment in Parkinson's disease using serum bile acid profiles and machine learningTong Shen, Can Cui, Ruiqi Liu, et al.NPJ Parkinson'S Disease|April 21, 2022
Cdk5 phosphorylation-induced SIRT2 nuclear translocation promotes the death of dopaminergic neurons in Parkinson's diseaseJianguo Yan, Pei Zhang, Jie Tan, et al.NPJ Parkinson'S Disease|April 2, 2021
Improving estimation of Parkinson's disease risk-the enhanced PREDICT-PD algorithmJonathan P Bestwick, Stephen D Auger, Cristina Simonet, et al.NPJ Parkinson'S Disease|May 8, 2023
Time to workforce exit after a Parkinson's disease diagnosisJonathan Timpka, Örjan Dahlström, Maria H Nilsson, et al.NPJ Parkinson'S Disease|May 10, 2023
Shared molecular genetic factors influence subcortical brain morphometry and Parkinson's disease riskLuis M García-Marín, Paula Reyes-Pérez, Santiago Diaz-Torres, et al.NPJ Parkinson'S Disease|April 7, 2023
Neuroprotective actions of a fatty acid nitroalkene in Parkinson's diseaseRoberto Di Maio, Matthew T Keeney, Veronika Cechova, et al.Pageof 141